Cross-Sector entity

Biotech

Technology
6

Cleantech is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in market-trends, which accounts for 1 of those 2, with the remainder spread across 1 other category. Biotech appears in 2 tracked Cross-Sector stories from February 19, 2026.

2 verified stories tracked

Last mentioned: Feb 19, 2026

Entity pulse

Recent coverage · Biotech

2 stories
6 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Biotech

Cleantech is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in market-trends, which accounts for 1 of those 2, with the remainder spread across 1 other category. Biotech appears in 2 tracked Cross-Sector stories from February 19, 2026. The tracked stories average 2 original sources each.

Stories tracked
2
Sources per story
2

Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Biotech. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Biotech 2

Finance markets Negative 6

Swiss Fintech Stagnates as Capital Migrates to Biotech and Cleantech

Switzerland's fintech sector faced a challenging funding environment in 2025, as venture capital increasingly flowed toward biotech, cleantech, and ICT. This shift highlights a strategic pivot by investors toward deep-tech and sustainability-focused enterprises, challenging Switzerland's traditional dominance in financial innovation.

2 sources